Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
tDCS for Hallucinations in First-Episode Schizophrenia
NCT02661347Withdrawn
- Sponsor
- Northwell Health
- Start
- Feb 2016
- Primary completion
- Dec 2016
- Countries
- 1
01
Overview
Randomised, double-blind trial (2 arms), sponsored by Northwell Health. Primary endpoint: Auditory Hallucinations Rating Scale at 16 weeks. Planned start Feb 2016; status: withdrawn.
Beyond the preview
Go deeper on NCT02661347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02661347.